Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Xiong, Yue  [Clear All Filters]
2014
Zhao D, Mo Y, Li M-T, Zou S-W, Cheng Z-L, Sun Y-P, Xiong Y, Guan K-L, Lei Q-Y. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Invest. 2014.
Yang H, Lin H, Xu H, Zhang L, Cheng L, Wen B, Shou J, Guan K, Xiong Y, Ye D. TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites. Cell Res. 2014.
2020
Cheng Z-L, Zhang M-L, Lin H-P, Gao C, Bin Song J-, Zheng Z, Li L, Zhang Y, Shen X, Zhang H, et al. The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming. Cell Rep. 2020;32(2):107877.
2021
Xiong Y, Chen Y, Huang X, Yang Z, Zhang J, Yu X, Fang J, Tao J, You K, Cheng Z, et al. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. Life Sci. 2021:119000.
2023
Yang Z, Huang X, Zhang J, You K, Xiong Y, Fang J, Getachew A, Cheng Z, Yu X, Wang Y, et al. Hepatic DKK1-driven steatosis is CD36 dependent. Life Sci Alliance. 2023;6(1).
Ma C, Li Q, Yang Y, Ge L, Cai J, Wang J, Zhu M, Xiong Y, Zhang W, Xie J, et al. mTOR hypoactivity leads to trophectoderm cell failure by enhancing lysosomal activation and disrupting the cytoskeleton in preimplantation embryo. Cell Biosci. 2023;13(1):219.
Chen Y-J, Li G-N, Li X-J, Wei L-X, Fu M-J, Cheng Z-L, Yang Z, Zhu G-Q, Wang X-D, Zhang C, et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Sci Adv. 2023;9(17):eadg0654.
2024
Joshi J, Xiong Y, Kuhn M, Radcliff AB, Baker TL, Watters JJ, Arendt LM. Gestational Intermittent Hypoxia Enhances Mammary Stem Cells and Alters Tumor Phenotype in Adult Female Offspring. Cells. 2024;13(3).